PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0007131|non-small cell lung cancer |
| Sentences | 8 |
| PubMedID- 25131571 | lung cancer, including non-small cell lung cancer, remains prevalent in australia and has a very poor survival rate. |
| PubMedID- 23552402 | lung cancer, predominantly non-small cell lung cancer (nsclc), is the first cause of cancer deaths worldwide, resulting in about one million deaths each year. |
| PubMedID- 23205280 | Methods: lung function tests were performed to lung cancer patients with non-small cell lung cancer of stage i, ii, iii and iv (241 patients in total). |
| PubMedID- 24215488 | lung cancer, with non-small cell lung cancer (nsclc) constituting 85% of cases, retains its position as one of the most commonly diagnosed cancer forms globally. |
| PubMedID- 23532607 | lung cancer, predominantly non-small cell lung cancer (nsclc), is currently the most common cause of malignancy-related death in the world. |
| PubMedID- 25383445 | Particle therapy for clinically diagnosed stage i lung cancer: comparison with pathologically proven non-small cell lung cancer. |
| PubMedID- 24280722 | The objective of this study was to compare lung cancer survival in patients with non-small cell lung cancer with a diameter of 30 mm or less with clinical stage 1 disease who underwent lobectomy or sublobar resection. |
| PubMedID- 22192801 | Calcyclin (m/z= 10,094.7) was identified to be underexpressed in small cell lung cancers, as compared with non-small cell lung cancers and normal lung tissue. |
Page: 1